+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liothyronine"

Endocrinology Drugs Market Report 2025 - Product Thumbnail Image

Endocrinology Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Thumbnail Image

Hormone Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Hypothyroidism - Pipeline Review, H2 2020 - Product Thumbnail Image

Hypothyroidism - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 35 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Liothyronine is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is also used to treat goiter, an enlarged thyroid gland, and to treat thyroid cancer. Liothyronine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders. Liothyronine is available in both brand-name and generic forms. It is available as a tablet, capsule, and liquid solution. It is usually taken once a day, but the dosage and frequency may vary depending on the patient's condition. Companies in the Liothyronine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more